K. Wingårdh

发表

Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry

S. Strand, C. Hindorf, O. Lindén, 2002, Cancer.

Scintigraphic method to quantify the passage from brain parenchyma to the deep cervical lymph nodes in rats

S. Strand, H. Widner, B. Jönsson, 2004, European Journal of Nuclear Medicine.

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

O. Nilsson, H. Lilja, S. Strand, 2012, Cancer biotherapy & radiopharmaceuticals.

Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy

S. Strand, C. Hindorf, O. Lindén, 2005, Acta oncologica.

Development and evaluation of a pharmacokinetic model for prediction of radioimmunotherapy based on pretherapy data.

S. Strand, O. Lindén, K. S. Gleisner, 2009, Cancer biotherapy & radiopharmaceuticals.

Carbohydrate groups of alpha1-microglobulin are important for secretion and tissue localization but not for immunological properties.

K Wingårdh, T. Cedervall, T. Olofsson, 2000, Glycobiology.

Distribution of iodine 125-labeled alpha1-microglobulin in rats after intravenous injection.

S. Strand, J. Larsson, L. Lögdberg, 2001, The Journal of laboratory and clinical medicine.

99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes

Linda Knutsson, Freddy Ståhlberg, Jimmy Lätt, 2012, The Journal of Nuclear Medicine.

90Y Bremsstrahlung Imaging for Absorbed-Dose Assessment in High-Dose Radioimmunotherapy

Michael Ljungberg, David Minarik, Sven-Erik Strand, 2010, The Journal of Nuclear Medicine.

Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.

T Ohlsson, K Sjögreen, M Ljungberg, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Single tumor cell uptake and dosimetry of technetium‐99m Fab′ anti‐CD22 in low‐grade B‐cell lymphoma

S. Strand, C. Hindorf, O. Lindén, 2002 .

177Lu‐[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy

Michael Ljungberg, Sven-Erik Strand, M. Ljungberg, 2010, Cancer.

131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.

S. Strand, T. Ohlsson, C. Hindorf, 2002, Acta oncologica.

The LundADose method for planar image activity quantification and absorbed-dose assessment in radionuclide therapy.

Michael Ljungberg, Katarina Sjögreen, David Minarik, 2005, Cancer biotherapy & radiopharmaceuticals.

Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy

S. Strand, K. Wingårdh, 2004, European Journal of Nuclear Medicine.

Parametric Images of Antibody Pharmacokinetics Based on Serial Quantitative Whole-Body Imaging and Blood Sampling

Katarina Sjögreen Gleisner, Kjell Erlandsson, Sven-Erik Strand, 2007, Journal of Nuclear Medicine.